Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Salma N. Tammam"'
Autor:
Mirna Samir, Reham M. Abdelkader, Maryam Shetab Boushehri, Samar Mansour, Alf Lamprecht, Salma N. Tammam
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 184:16-24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e82a73462bf1ff7b7457126771d2057
https://doi.org/10.1016/j.ejpb.2023.01.006
https://doi.org/10.1016/j.ejpb.2023.01.006
Autor:
Suzan Fangary, Mohammad Abdel-Halim, Reem K. Fathalla, Raghda Hassan, Noha Farag, Matthias Engel, Samar Mansour, Salma N. Tammam
Increasing antibiotic concentrations within bacterial cells while reducing them in mammalian ones would ultimately result in an enhancement of antibacterial actions, overcoming multidrug resistance, all while minimizing toxicity. Nanoparticles (NPs)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12268775e1ca6d6620043f55ec2a3634
Autor:
Aya A. Ezzat, Salma N. Tammam, Rasha S. Hanafi, Omar Rashad, Aya Osama, Eman Abdelnaby, Sameh Magdeldin, Samar Mansour
Publikováno v:
Molecular pharmaceutics. 19(5)
The nanoparticle (NP) protein corona represents an interface between biological components and NPs, dictating their cellular interaction and biological fate. To assess the success of cellular targeting, NPs modified with targeting ligands are incubat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d88177f7a0b4d20ef0122c5084879781
https://pubmed.ncbi.nlm.nih.gov/35380849
https://pubmed.ncbi.nlm.nih.gov/35380849
Autor:
Lama A. Helmy, Mohammed Abdel-Halim, Raghda Hassan, Aya Sebak, Haithem A.M. Farghali, Samar Mansour, Salma N. Tammam
Publikováno v:
Colloids and Surfaces B: Biointerfaces. 211:112289
Due to its overexpression in cancer cells, the folate receptor (FR) is heavily exploited in the active targeting of nanoparticles (NPs). Its ligand, folic acid (FA) is as a consequence widely used as a NP targeting ligand. Although rather popular and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d16f8291c1ae469458e1ad181d60926
https://doi.org/10.1016/j.colsurfb.2021.112289
https://doi.org/10.1016/j.colsurfb.2021.112289
Autor:
Salma N. Tammam, Menna Azzam, Twan Lammers, Sara El Safy, Samar Mansour, Federica De Lorenzi, Ralf Weiskirchen, Sarah A Abdelgelil, Anastasia Asimakopoulou
Publikováno v:
Pharmaceutics, Vol 12, Iss 590, p 590 (2020)
Pharmaceutics 12(6), 590 (2020). doi:10.3390/pharmaceutics12060590 special issue: "Special Issue "Lipid-and/or Polymer-Based Drug Delivery Systems" / Special Issue Editors: Prof. Emanuela Fabiola Craparo, Guest Editor; Prof. Dr. Teresa Musumeci, Guest Editor"
Pharmaceutics
Volume 12
Issue 6
Pharmaceutics 12(6), 590 (2020). doi:10.3390/pharmaceutics12060590 special issue: "Special Issue "Lipid-and/or Polymer-Based Drug Delivery Systems" / Special Issue Editors: Prof. Emanuela Fabiola Craparo, Guest Editor; Prof. Dr. Teresa Musumeci, Guest Editor"
Pharmaceutics
Volume 12
Issue 6
Activated hepatic stellate cells (aHSCs) are the main orchestrators of the fibrotic cascade in inflamed livers, with transforming growth factor-beta (TGF-&beta
) being the most potent pro-fibrotic cytokine. Hence, aHSCs serve as interesting ther
) being the most potent pro-fibrotic cytokine. Hence, aHSCs serve as interesting ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53077aed5e086e0b25fcf9594645c625
Autor:
Salma N. Tammam
Publikováno v:
Current Pharmaceutical Design. 23:6714-6729
BACKGROUND Multidrug resistance in cancer is the ability of a cancer cell to resist treatment with a wide range of structurally and functionally dissimilar chemotherapeutics. The resistant phenotype could arise in response to several cellular changes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3416853c4dca6090ab3e4135de3c8e9d
https://doi.org/10.2174/1381612823666171122104738
https://doi.org/10.2174/1381612823666171122104738
Publikováno v:
Pharmacological Research. 126:2-30
Multidrug resistance (MDR) is associated with a wide range of pathological changes at different cellular and intracellular levels. Nanoparticles (NPs) have been extensively exploited as the carriers of MDR reversing payloads to resistant tumor cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5760bebb04f93ccebb30191b06a1a634
https://doi.org/10.1016/j.phrs.2017.07.023
https://doi.org/10.1016/j.phrs.2017.07.023
Publikováno v:
International Journal of Pharmaceutics. 606:120879
Channelopathies are disorders caused by reduced expression or impaired function of ion channels. Most current therapies rely on symptomatic treatment without addressing the underlying cause. We have recently established proof of principle for deliver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ab443050dd0b42534621c56e6a55b14
https://doi.org/10.1016/j.ijpharm.2021.120879
https://doi.org/10.1016/j.ijpharm.2021.120879
Publikováno v:
Journal of Controlled Release. 253:30-36
The cell nucleus is an interesting target in many diseases with particular interest in cancer. Previously, nuclear targeted small and large chitosan nanoparticles (S-NPs≈25nm, and L-NPs≈150nm respectively), modified with low, intermediate and hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc65090901159e9d95bc56112e7e6822
https://doi.org/10.1016/j.jconrel.2017.02.029
https://doi.org/10.1016/j.jconrel.2017.02.029
Autor:
Hassan M.E. Azzazy, Hosam Zaghloul, Asma Althani, Salma N. Tammam, Mahmoud A.F. Khalil, Eman Abdul Gawad
Publikováno v:
Carbohydrate Polymers. 164:57-63
A platform for nucleic acid detection employing chitosan and chitosan coated gold nanoparticles (AuNPs) was developed. Mycobacterium tuberculosis (MTB) was used as a model target. MTB DNA was extracted from sputum using simple total nucleic acid extr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85ba6296aa41490e27bf766a5d18aa97
https://doi.org/10.1016/j.carbpol.2017.01.051
https://doi.org/10.1016/j.carbpol.2017.01.051